Conveniently scheduled in the mornings during the week of December 6, 2010, these programs are designed to keep you up to date on the latest developments impacting your business. You are invited to attend one, some, or all of the sessions.
Topics to be covered include:
- What Every Corporate Counsel Should Know About Executory Contracts in Bankruptcy
- Dealer and Distributor Terminations and Litigation
- Economic Uncertainty and Your Credit Facilities
- What Every Corporate Counsel Should Know About Attorney-Client Privilege and Work Product
- Update on Dodd-Frank Act Executive Compensation and Corporate Governance Provisions
- What Every Corporate Counsel Should Know About Antitrust
- Emerging Issues in Intellectual Property
- What Every General Counsel Should Know About Executive Compensation Tax Issues
- What Every Corporate Counsel Should Know About Environmental Enforcement Trends and Emerging Environmental Regulations
- Ethics 2010
Year in Review: A Continuing Legal Education Program Series is part of the Foley Executive Briefing Series.
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.